Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $162B |
| FY2017, ended Dec 31, 2017 | $152B |
| FY2018, ended Dec 31, 2018 | $197B |
| FY2019, ended Dec 31, 2019 | $231B |
| FY2020, ended Dec 31, 2020 | $207B |
| FY2021, ended Dec 31, 2021 | $194B |
| FY2022, ended Dec 31, 2022 | $282B |
| FY2023, ended Dec 31, 2023 | $276B |
| FY2024, ended Dec 31, 2024 | $251B |
| FY2025, ended Dec 31, 2025 | $260B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $317B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $39.8B |
| FY2017, ended Dec 31, 2017 | $40.1B |
| FY2018, ended Dec 31, 2018 | $42.3B |
| FY2019, ended Dec 31, 2019 | $39.1B |
| FY2020, ended Dec 31, 2020 | $41.5B |
| FY2021, ended Dec 31, 2021 | $48.7B |
| FY2022, ended Dec 31, 2022 | $59.3B |
| FY2023, ended Dec 31, 2023 | $60.1B |
| FY2024, ended Dec 31, 2024 | $64.2B |
| FY2025, ended Dec 31, 2025 | $65.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $66.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.92B | $8.76B |
| FY2017, ended Dec 31, 2017 | $2.39B | $4.56B |
| FY2018, ended Dec 31, 2018 | $6.22B | $8.31B |
| FY2019, ended Dec 31, 2019 | $9.84B | $10.1B |
| FY2020, ended Dec 31, 2020 | $7.07B | $5.82B |
| FY2021, ended Dec 31, 2021 | $13.0B | $8.67B |
| FY2022, ended Dec 31, 2022 | $14.5B | $14.7B |
| FY2023, ended Dec 31, 2023 | $365M | $9.14B |
| FY2024, ended Dec 31, 2024 | $17.1B | $18.1B |
| FY2025, ended Dec 31, 2025 | $18.3B | $12.4B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $3.17B | $16.1B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $6.51B |
| FY2017, ended Dec 31, 2017 | $6.09B |
| FY2018, ended Dec 31, 2018 | $7.96B |
| FY2019, ended Dec 31, 2019 | $9.68B |
| FY2020, ended Dec 31, 2020 | $8.05B |
| FY2021, ended Dec 31, 2021 | $8.10B |
| FY2022, ended Dec 31, 2022 | $12.7B |
| FY2023, ended Dec 31, 2023 | $6.84B |
| FY2024, ended Dec 31, 2024 | $13.2B |
| FY2025, ended Dec 31, 2025 | $14.6B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.85B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $24.8B |
| FY2017, ended Dec 31, 2017 | $24.4B |
| FY2018, ended Dec 31, 2018 | $25.1B |
| FY2019, ended Dec 31, 2019 | $26.3B |
| FY2020, ended Dec 31, 2020 | $31.8B |
| FY2021, ended Dec 31, 2021 | $33.1B |
| FY2022, ended Dec 31, 2022 | $30.7B |
| FY2023, ended Dec 31, 2023 | $35.1B |
| FY2024, ended Dec 31, 2024 | $37.1B |
| FY2025, ended Dec 31, 2025 | $49.3B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $53.9B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 10.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 2.75B |
| FY2017, ended Dec 31, 2017 | 2.70B |
| FY2018, ended Dec 31, 2018 | 2.58B |
| FY2019, ended Dec 31, 2019 | 2.54B |
| FY2020, ended Dec 31, 2020 | 2.53B |
| FY2021, ended Dec 31, 2021 | 2.53B |
| FY2022, ended Dec 31, 2022 | 2.54B |
| FY2023, ended Dec 31, 2023 | 2.53B |
| FY2024, ended Dec 31, 2024 | 2.53B |
| FY2025, ended Dec 31, 2025 | 2.47B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 2.47B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $3.43B | $300M |
| FY2017, ended Dec 31, 2017 | $4.01B | $312M |
| FY2018, ended Dec 31, 2018 | $9.09B | $348M |
| FY2019, ended Dec 31, 2019 | $4.78B | $388M |
| FY2020, ended Dec 31, 2020 | $1.28B | $441M |
| FY2021, ended Dec 31, 2021 | $840M | $479M |
| FY2022, ended Dec 31, 2022 | $0 | $541M |
| FY2023, ended Dec 31, 2023 | $1.35B | $645M |
| FY2024, ended Dec 31, 2024 | $1.31B | $761M |
| FY2025, ended Dec 31, 2025 | $5.08B | $820M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $4.21B | $892M |
Valuation
At current price- Market Cap
- $350B
- P/E
- 110×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 5.3×
- Price / Book
- 8.3×
- EV / EBITDA
- 36.4×
Growth
Trailing 12 months- Revenue (TTM)
- $66.6B
- Revenue Growth YoY
- 4.6%
- Revenue CAGR 3Y
- 3.1%
- Revenue CAGR 5Y
- 9.4%
- EPS Growth YoY
- −80.7%
- Net Income Growth YoY
- −80.7%
Profitability
Trailing 12 months- Gross Margin
- 73.0%
- Operating Margin
- —
- Net Margin
- 4.8%
- FCF Margin
- 24.1%
- Return on Equity
- 7.0%
Earnings
Trailing 12 months- Net Income
- $3.17B
- EPS (diluted)
- $1.25
- EBITDA
- $10.9B
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $6.85B
- Total Debt
- $53.9B
- Net Debt
- $47.1B
- Total Assets
- $130B
- Total Liabilities
- $87.8B
- Shareholders' Equity
- $41.9B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $20.0B
- Capital Expenditure
- $3.90B
- Free Cash Flow
- $16.1B
Dividends and risk
Last 12 months- Dividend Yield
- 2.4%
- Dividend / Share
- $3.40
- Beta (5Y)
- 0.20
Every ratio is calculated from the company’s reported figures.